Author

Alexa J. Basilio

Observed name: Alexa Basilio

Institutions: McKesson (United States), The US Oncology Network

Observed institutions: McKesson (United States), Emory University, Moffitt Cancer Center, The US Oncology Network, Winship Cancer Institute

ORCID: 0000-0003-3872-0508

Observed ORCID: 0000-0003-3872-0508

OpenAlex ID: A5037284385

Impact of empirically eliminating 5-fluorouracil (5-FU) bolus and leucovorin (LV) in patients with metastatic colorectal cancer (mCRC) receiving first-line treatment with mFOLFOX6.

2020 · Alexa Basilio, Anand Shah, et al. · Journal of Clinical Oncology · 5

Metastatic Melanoma Treatment with Pembrolizumab after Hypersensitivity Reaction to Nivolumab: A Case Report

2023 · Alyssa R. Cruse, Alexa J. Basilio, et al. · Case Reports in Oncology · 4

Remote Clinical Pharmacist Impact on Reducing Total Cost of Care in Enhancing Oncology Model–Enrolled Oncology Practices

2025 · Daniel C. Kendzierski, Alexa J. Basilio, et al. · JCO Oncology Practice · 2

Remote clinical pharmacist impact on reducing total cost of care in Enhancing Oncology Model–enrolled oncology practices.

2025 · Daniel Kendzierski, Alexa Basilio, et al. · Journal of Clinical Oncology

Evaluation of bleeding risk between apixaban and rivaroxaban in patients with gastrointestinal cancer.

2023 · Parker Gundersen, Alexa Basilio, et al. · Journal of Clinical Oncology

Works count: 5

Citation count: 11

H-index: 2

I10-index: